Brain Cancer
Northwest Biotherapeutics updates brain cancer clinical data
Published in Vaccine Weekly, September 27th, 2006
The report was given at the Cambridge Healthtech Institute's 3rd Annual Cancer Immunotherapeutics and Vaccines Conference in Boston, Mass.
Ongoing findings from the two Phase I clinical trials for DCVax-Brain were as follows. Seven of 16 patients are still alive, with follow-up times ranging from 18 to 75 months; six of these seven patients have shown no cancer recurrence.
In a landmark analysis at 24 months, 63% of treated patients were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-09-27)
More Articles from Vaccine Weekly
- Measles Vaccine
Time to intervene with vaccination campaign may be longer than thought during measles epidemic - Radiation Damage
Salmonella carrying platelet factor 4 cDNAs protects against radiation - Staphylococcal Vaccine
Antigenic components of Staphylococcus epidermidis have been identified - Tuberculosis Vaccine
Early clinical trials are testing new tuberculosis vaccine - Alzheimer Disease
New results published on Pharmexa's PADRE epitope in Alzheimer vaccine - Anthrax Vaccine
U.S. Department of Homeland Security certifies anthrax vaccine adsorbed as approved product - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
